Scholarlink

<p>Cannabinoids, such as Δ<sup>9</sup>-tetrahydrocannabinol (THC), produce anxiety at high doses, yet the underlying neural mechanisms remain poorly understood. The anterior cingulate cortex (ACC) sends dense monosynaptic projections to the dorsomedial striatum (DMS). Optogenetic excitation of the ACC → DMS pathway promotes anxiolytic-like behavior, suggesting that its suppression could induce anxiogenic states. We hypothesized that CB1 receptor-mediated suppression of this circuit contributes to cannabinoid-induced anxiogenic effects. We found that endocannabinoid (eCB) system components are expressed in ACC → DMS neurons and that cannabinoids depress excitatory transmission in this circuit in mice. Additionally, in vivo fiber photometry revealed that anxiogenic and aversive stimuli trigger eCB release from the DMS, which activates CB1 receptors on ACC axon terminals. Notably, pathway-specific deletion of CB1 receptors in the ACC → DMS circuit reduced both innate anxiety-like behaviors and conditioned place aversion to THC in mice. Collectively, these findings identify a circuit-level mechanism whereby cannabinoid signaling promotes anxiety and aversion.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

CB1 receptor signaling at the cingulate-striatal circuit is anxiogenic

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月8日

查看全文
  • Thomas J. Kelly,
  • Xiaojie Liu,
  • Yao Huang,
  • Ying Hu,
  • Vladislav Friedman,
  • Cecilia J. Hillard,
  • Qing-song Liu

摘要

Cannabinoids, such as Δ9-tetrahydrocannabinol (THC), produce anxiety at high doses, yet the underlying neural mechanisms remain poorly understood. The anterior cingulate cortex (ACC) sends dense monosynaptic projections to the dorsomedial striatum (DMS). Optogenetic excitation of the ACC → DMS pathway promotes anxiolytic-like behavior, suggesting that its suppression could induce anxiogenic states. We hypothesized that CB1 receptor-mediated suppression of this circuit contributes to cannabinoid-induced anxiogenic effects. We found that endocannabinoid (eCB) system components are expressed in ACC → DMS neurons and that cannabinoids depress excitatory transmission in this circuit in mice. Additionally, in vivo fiber photometry revealed that anxiogenic and aversive stimuli trigger eCB release from the DMS, which activates CB1 receptors on ACC axon terminals. Notably, pathway-specific deletion of CB1 receptors in the ACC → DMS circuit reduced both innate anxiety-like behaviors and conditioned place aversion to THC in mice. Collectively, these findings identify a circuit-level mechanism whereby cannabinoid signaling promotes anxiety and aversion.